Melanie Senior. Show Affiliations »
Abstract
Mesh： See more » Biosimilar Pharmaceuticals/adverse effectsBiosimilar Pharmaceuticals/economicsBiosimilar Pharmaceuticals/pharmacologyDrug Approval/economicsDrug Approval/legislation & jurisprudenceDrug Industry/economicsDrug Industry/legislation & jurisprudenceEuropeHumansLegislation as TopicMarketing/economicsUnited StatesUnited States Food and Drug Administration
Substances： See more » Biosimilar Pharmaceuticals
Year: 2013 PMID： 23563402 DOI： 10.1038/nbt0413-269
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908